Saving the World's women from cervical cancer

New England Journal of Medicine

Volumn 374, Issue 26, 2016, Pages 2509-2511

  Tsu, Vivien ^a   Jerónimo, José ^a  

^a Appropriate Technology in Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; WART VIRUS VACCINE;

BIOPSY; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; COLPOSCOPY; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; LOWEST INCOME GROUP; MEDICAL INFORMATION; PAPANICOLAOU TEST; PRECANCER; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY; UTERINE CERVIX CANCER; VACCINATION; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH; INCIDENCE; MASS SCREENING; PROCEDURES; UTERINE CERVICAL NEOPLASMS;

EARLY DETECTION OF CANCER; FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; MASS SCREENING; UTERINE CERVICAL NEOPLASMS;

EID: 84976507215     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1604113     Document Type: Review

References (5)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012: estimated cancer incidence, mortality, and prevalence worldwide in 2012. Lyon, France: International Agency for Research on Cancer, 2013 (http://globocan.iarc.fr).
2. Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 2016; 1 37: 1-9.
3. Schiffman M, Wentzensen N. A suggested approach to simplify and improve cervical screening in the United States. J Low Genit Tract Dis 2016; 20: 1-7.
4. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of non-communicable diseases. Geneva: World Economic Forum, 2011.
5. Campos NG, Tsu V, Jeronimo J, et al. When and how often to screen for cervical cancer in three low-and middle-income countries: a cost-effectiveness analysis. Papillomavirus Res 2015; 1:38-58.